Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Exemestane - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for exemestane and what is the scope of exemestane freedom to operate?

is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, West-ward Pharms Int, Pharmacia And Upjohn, and Alvogen Malta, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for exemestane. Six suppliers are listed for this compound.

Summary for Generic Name: exemestane

Drug Master File Entries: see list15
Suppliers / Packagers: see list6
Bulk Api Vendors: see list69
Clinical Trials: see list80
Patent Applications: see list6,769
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:exemestane at DailyMed

Pharmacology for Ingredient: exemestane

Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
TABLET;ORAL077431-001Apr 1, 2011ABRXNoNo► Subscribe► Subscribe
Alvogen Malta
TABLET;ORAL200898-001Jul 28, 2014ABRXNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
TABLET;ORAL020753-001Oct 21, 1999ABRXYesYes► Subscribe► Subscribe
Mylan Pharms Inc
TABLET;ORAL203315-001Mar 10, 2017ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus